SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Intervirology. 2008;51(2):70-4.

Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.

, , , , , , , ,

제1저자 이동헌 · 교신저자 정숙향

PMID 18434743 DOI 10.1159/000127428 IF 1.8 소화기내과
소속 (1)
  1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Korea.

Abstract

OBJECTIVE The number of adult hepatitis A cases has progressively been increasing during the last several years in Korea. The aim of the present study was to describe the recent clinical features of hepatitis A and the seroprevalence of hepatitis A virus (HAV), and to discuss HAV vaccine strategy in Korea.

METHODS Retrospective analysis of clinical characteristics of hepatitis A from 109 patients consecutively enrolled at a community hospital between 2003 and 2006 as well as cross-sectional study of seroprevalence of HAV from 307 patients of hospital population group during the same period were performed.

RESULTS Most hepatitis A cases were young adults in their twenties or thirties, and the severity of the disease was related to the age of patients. The seroprevalence of HAV was 62%, which was dependent on the age of patients. HAV seroepidemiology in Korea is rapidly changing and a growing number of young adults are susceptible to HAV infection.

CONCLUSIONS The clinical features and the epidemiological shift of HAV urge Korea, as well as other countries which are experiencing similar issues, to promote childhood vaccination and consider catch-up vaccination for adolescents and young adults.

Copyright 2008 S. Karger AG, Basel.

그 밖의 정보
출판 형태
Journal Article
저널
Intervirology · eISSN 1423-0100
전자 출판
2008-04-22
MeSH
Adolescent · Adult · Child · Child, Preschool · Female · Hepatitis A / epidemiology / physiopathology / prevention & control · Hepatitis A Antibodies / blood · Hepatitis A Vaccines / administration & dosage · Hepatitis A Virus, Human / immunology · Hospitalization · Humans · Infant · Korea / epidemiology · Male · Middle Aged · Severity of Illness Index · Vaccination
Substances
Hepatitis A Antibodies · Hepatitis A Vaccines